Related Experiment Videos
Endodermal sinus tumor of the vagina
Monica Terenziani1, Filippo Spreafico, Paola Collini
1Pediatric Oncology Unit, Istituto Nazionale Tumori, Milano, Italy. monica.terenziani@istitutotumori.mi.it
Pediatric Blood & Cancer
|October 4, 2005
Summary
Platinum-based chemotherapy, specifically the PEB regimen, effectively treated two cases of vaginal endodermal sinus tumors, leading to complete remission and sustained disease-free survival without extensive surgery.
Area of Science:
- Gynecologic Oncology
- Pediatric Oncology
- Medical Oncology
Background:
- Vaginal germ cell tumors are rare but critical for effective local treatment.
- Endodermal sinus tumors (ESTs) are a specific type of malignant germ cell tumor.
- Optimal treatment strategies for vaginal ESTs require further investigation.
Observation:
- The study details the experience with two patients diagnosed with vaginal endodermal sinus tumors.
- Both patients received the PEB (cisplatin, etoposide, bleomycin) chemotherapy regimen.
- One patient presented with a residual lesion post-chemotherapy, which was confirmed as non-viable tumor tissue upon repeated biopsy.
Findings:
- Treatment with the PEB regimen resulted in significant tumor regression and normalization of alpha-fetoprotein levels in both patients.
- Both patients achieved complete remission and remained alive and disease-free.
- Complete remission was achieved without the need for radical surgical intervention, with biopsies being the only surgical procedures performed.
Implications:
- Platinum-based chemotherapy, exemplified by the PEB regimen, demonstrates high efficacy in treating vaginal endodermal sinus tumors.
- These findings suggest that chemotherapy should be a primary consideration for managing vaginal ESTs.
- Conservative management, including chemotherapy with biopsies, may be a viable alternative to extensive surgery, preserving quality of life.